Clinical Trials Sponsored by Humana Co.Ltd.

Total 3836 results

Evidation Health
Humana Co.Ltd.

Completed

Diabetes Coaching Program for Medicare Advantage Members With Type 2 Diabetes - Impact on A1c

Diabetes Mellitus, Type 2

United States
Evidation Health
Humana Co.Ltd.

Completed

Digital Self-Management Program for Medicare Advantage Members With Type 2 Diabetes- Impact on A1c

Diabetes Mellitus, Type 2

United States
Humana Co.Ltd.
Vitkovice Hospital

Completed

Effect of Galactooligosaccharides on Incidence of Atopic Manifestations in Infants

Atopic Dermatitis

Czech Republic
Harvard Medical School (HMS and HSDM)
Humana Co.Ltd.

Completed

Racial Inequality in Inhaler Fills for COPD - A Trial of Reduced Cost-Sharing

Chronic Obstructive Pulmonary Disease

United States
NKBio Co.Ltd.

Unknown

Biocell Natural Killer Mixture in Diffuse Large B Cell Lymphoma (DLBCL) Patients (NKCell)

Diffuse Large B-cell Lymphoma

Korea, Republic of
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...
Humana Co.Ltd.

Completed

Clinical Evaluation of a Low Protein Content Formula in the First Months of Life: a RCT

Safety Issues | Infant Nutrition Disorders

Italy
Keymed Biosciences Co.Ltd

Not yet recruiting

Study on the Treatment of Prurigo Nodularis With Stapokibart Injection

Prurigo Nodularis
Keymed Biosciences Co.Ltd

Not yet recruiting

Study of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis

Chronic Rhinosinusitis With Nasal Polyps

China
Keymed Biosciences Co.Ltd

Not yet recruiting

Study of CM310 Injection in Adolescent Subjects With Atopic Dermatis

Atopic Dermatitis

China
Keymed Biosciences Co.Ltd

Not yet recruiting

Study of CM310 in Children Subjects With Moderate-to-severe Atopic Dermatis

Atopic Dermatitis
Keymed Biosciences Co.Ltd

Not yet recruiting

Study of CM310 in Patients With Allergic Rhinitis

Allergic Rhinitis
Keymed Biosciences Co.Ltd

Recruiting

Study of CM326 Injection in Healthy Subjects

Healthy

China
Keymed Biosciences Co.Ltd

Recruiting

Study of CM310 Injection in Subjects With Moderate-to-Severe Atopic Dermatitis

Atopic Dermatitis

China
Keymed Biosciences Co.Ltd

Recruiting

The Study of CM326 in Adult Subjects With Atopic Dermatitis

Atopic Dermatitis

China
TCRx Therapeutics Co.Ltd

Recruiting

KSH01-R02-101 Solid Tumors

Solid Tumor

China
TCRx Therapeutics Co.Ltd

Recruiting

KSH01-TCRT Solid Tumors (KSH01-TCRT)

Refractory Solid Tumors | Relapsed Solid Tumors | TCR-T Cells

China
Keymed Biosciences Co.Ltd

Not yet recruiting

A Study of CM310 in Subjects With Chronic Pruritus

Chronic Pruritus of Unknown Origin
Keymed Biosciences Co.Ltd

Not yet recruiting

A Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （CROWNS-2）

Chronic Rhinosinusitis With Nasal Polyposis
Keymed Biosciences Co.Ltd

Recruiting

Single Ascending Dose Study of CM338 in Healthy Volunteers

Healthy

China
Keymed Biosciences Co.Ltd

Recruiting

The Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyps

Chronic Rhinosinusitis With Nasal Polyps

China
Keymed Biosciences Co.Ltd

Completed

Single Ascending Dose Study of CM326 in Healthy Volunteers

Asthma

China
Keymed Biosciences Co.Ltd

Not yet recruiting

Single Dose Escalation Study of CM383 in Healthy Volunteers

Alzheimer Disease
Keymed Biosciences Co.Ltd

Not yet recruiting

Study of CM310 in Subjects With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

China
Keymed Biosciences Co.Ltd

Not yet recruiting

A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis

Atopic Dermatitis
BioGend Therapeutics Co.Ltd

Recruiting

The Clinical Outcome of BiCRI in the Treatment of Chondral and Osteochondral Lesions

Articular Cartilage Disorder of Knee

Taiwan
TCRx Therapeutics Co.Ltd

Recruiting

KSX01-TCRT Injection Project in Solid Tumors

Refractory Solid Tumors | Relapsed Solid Tumors | TCR-T Cells

China
Keymed Biosciences Co.Ltd

Recruiting

Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy

IgA Nephropathy

China
Keymed Biosciences Co.Ltd

Recruiting

Study to Evaluate Pharmacokinetics, Safety and Efficacy of CM310

Healthy

China
Keymed Biosciences Co.Ltd

Recruiting

A Study of CM310 in Children Patients With Moderate-to-severe Atopic Dermatis

Atopic Dermatitis

China
Keymed Biosciences Co.Ltd

Recruiting

The Study of CM326 in Patients With Moderate-to-severe Atopic Dermatitis

Moderate-to-severe Atopic Dermatitis

China
Keymed Biosciences Co.Ltd

Recruiting

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901

Gastric Cancer | Pancreatic Cancer | Advanced Solid Tumor | Gastroesophageal Junction Adenocarcinoma

China
BioGend Therapeutics Co.Ltd

Active, not recruiting

OIF/β-TCP in Patients With Open Tibial Fractures in Need of Bone Grafting

Tibia Fracture

Taiwan
Keymed Biosciences Co.Ltd

Completed

A Study of CM310 in Subjects With Moderate to Severe Asthma

Asthma

China
Keymed Biosciences Co.Ltd

Active, not recruiting

Study of CM310 in Subjects With Allergic Rhinitis (PHECDA)

Allergic Rhinitis

China
Keymed Biosciences Co.Ltd

Completed

Study of CM310 in Healthy Subjects

Healthy

China
Keymed Biosciences Co.Ltd

Completed

A Multiple Ascending Doses Study of CM326 Injection in Healthy Subjects

Asthma

China
Keymed Biosciences Co.Ltd

Completed

Subcutaneously CM310/Placebo in Patients With Chronic Rhinosinusitis With Nasal Polyposis (CROWNS-1)

Chronic Rhinosinusitis (Diagnosis) | Nasal Polyps

China
Keymed Biosciences Co.Ltd

Completed

Dose Escalation Trial of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis (AD)

Moderate-to-severe Atopic Dermatitis

China
Keymed Biosciences Co.Ltd

Not yet recruiting

Study of CM313 in Healthy Subjects

Healthy
Keymed Biosciences Co.Ltd

Not yet recruiting

Study Evaluating the Pharmacokinetics of CM310 in Healthy Subjects

Healthy

China
Keymed Biosciences Co.Ltd

Recruiting

The Study of CM326 in Moderate-to-severe Atopic Dermatitis

Moderate-to-severe Atopic Dermatitis

China
Keymed Biosciences Co.Ltd

Not yet recruiting

A Study of CM313 Injection in Subjects With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
Keymed Biosciences Co.Ltd

Not yet recruiting

Multiple Ascending Dose Study of CM338 in Healthy Volunteers

Healthy Subjects
Keymed Biosciences Co.Ltd

Not yet recruiting

A Study of CM336 in Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma
Keymed Biosciences Co.Ltd

Recruiting

A Study of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis

Atopic Dermatitis

China
Keymed Biosciences Co.Ltd

Recruiting

A Study of CM350 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Keymed Biosciences Co.Ltd

Recruiting

The Study of CM310 in Patients With Atopic Dermatitis

Moderate-to-severe Atopic Dermatitis

China
Keymed Biosciences Co.Ltd

Recruiting

Dose Escalation and Expansion Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma and Lymphoma

Lymphoma | Multiple Myeloma

China
Keymed Biosciences Co.Ltd

Active, not recruiting

A Study of CM326 in Patients With Chronic Rhinosinusitis With Nasal Polyps (DUBHE)

Chronic Rhinosinusitis With Nasal Polyps

China
Keymed Biosciences Co.Ltd

Completed

Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD)

Moderate-to-severe Atopic Dermatitis

China

Clinical Trials Sponsored by Humana Co.Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations